Chimerization of the Anti-Viral CD8 + T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy.

MLA

Vile, Richard, et al. “Chimerization of the Anti-Viral CD8 + T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy.” Research Square, Nov. 2023. EBSCOhost, https://doi.org/10.21203/rs.3.rs-3576281/v1.

APA

Vile, R., Webb, M., van Vloten, J., Evgin, L., Sangsuwannukul, T., Kendall, B., Tonne, J., Thompson, J., Metko, M., Moore, M., Yerovi, M. C., McNiven, M., Monga, S., Borad, M., & Roberts, L. (2023). Chimerization of the Anti-Viral CD8 + T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy. Research Square. https://doi.org/10.21203/rs.3.rs-3576281/v1

Chicago

Vile, Richard, Mason Webb, Jacob van Vloten, Laura Evgin, Thanich Sangsuwannukul, Benjamin Kendall, Jason Tonne, et al. 2023. “Chimerization of the Anti-Viral CD8 + T Cell Response with A Broad Anti-Tumor T Cell Response Reverses Inhibition of Checkpoint Blockade Therapy by Oncolytic Virotherapy.” Research Square, November. doi:10.21203/rs.3.rs-3576281/v1.